1-4 of 4
Philip Savage
Close
Sort by
Journal Articles

Immortalized HLA Class I Negative Daudi B Cells Coated with HLA/Peptide Monomers Promote Efficient In Vitro Expansion of Antigen Specific CD8+ T Cells.

Linda D. Barber, PhD, Susan Jordan, BSc, Alison M.E. Whitelegg, Ph.D, J. Alejandro Madrigal, PhD, Philip Savage, PhD
Journal: Blood
Blood (2005) 106 (11): 3908.
https://doi.org/10.1182/blood.V106.11.3908.3908
Published: 2005
Journal Articles

Redirection of CMV Specific CTL towards B-CLL Via CD20 Targeted HLA/CMV Complexes.

Rogier Mous, MD, Philip Savage Savage, MD, Ester BM Remmerswaal, Rene A.W. van Lier, MD, PhD, Eric Eldering, Marinus H.J. Van Oers, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 449.
https://doi.org/10.1182/blood.V106.11.449.449
Published: 2005
Journal Articles

Use of B cell–bound HLA-A2 class I monomers to generate high-avidity, allo-restricted CTLs against the leukemia-associated protein Wilms tumor antigen

Brief Report
Philip Savage, Liquan Gao, Kevin Vento, Pam Cowburn, Stephen Man, Neil Steven, Graham Ogg, Andrew McMichael, Agamemnon Epenetos, Els Goulmy, Hans J. Stauss
Journal: Blood
Blood (2004) 103 (12): 4613–4615.
https://doi.org/10.1182/blood-2003-11-3903
Published: 2004
Journal Articles

Antibody-targeted MHC complex–directed expansion of HIV-1– and KSHV-specific CD8 + lymphocytes: a new approach to therapeutic vaccination

Brief Report
Justin Stebbing, Brian Gazzard, Steve Patterson, Mark Bower, Dhayaneethie Perumal, Mark Nelson, Andrew McMichael, Graham Ogg, Agamemnon Epenetos, Frances Gotch, Philip Savage
Journal: Blood
Blood (2004) 103 (5): 1791–1795.
https://doi.org/10.1182/blood-2003-09-3023
Published: 2004